Top Markets
Coin of the day
ReNeuron Group plc ReNeuron Group plc

ReNeuron Group plc

RENE
Rang in Aktien #41656
Established in 1997 and headquartered in Pencoed, UK, ReNeuron Group plc... Established in 1997 and headquartered in Pencoed, UK, ReNeuron Group plc focuses on the research, development, and commercialization of innovative cell-based therapies. The company is actively developing a CTX stem cell therapy candidate targeting stroke disability, which is currently at the partnering stage for distribution both within and outside China. Another significant pipeline asset is its human retinal progenitor cell therapy, now in Phase I/IIa clinical trials, designed to treat retinitis pigmentosa, a debilitating eye disease leading to blindness. Furthermore, ReNeuron is conducting pre-clinical investigations into CTX-derived exosomes, which are microscopic, information-carrying packages released by CTX cells. The firm also generates revenue through the licensing of its ReNcell products. Collaboratively, ReNeuron has partnered with University College London to explore the creation of immune cells from induced pluripotent stem cells for application in anti-cancer cell therapies.
Aktienkurs
$0.00042815
Zuletzt synchronisiert: 2024-02-27
Marktkapitalisierung
$13.55K
Veränderung (1 Tag)
0.03%
Veränderung (1 Jahr)
0.00%
Land
GB
Handel ReNeuron Group plc (RENE)

Kategorie

Kursverlauf für ReNeuron Group plc (RENE)
Höchster Schlusskurs: $0.00 am 2024-02-01

Niedrigster Schlusskurs: $0.36 am 2005-08-01
Kursverlauf der Aktie von ReNeuron Group plc von 2005 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2024 492.28%
2023 -66.21%
2022 -87.48%
2021 5.22%
2020 -36.63%
2019 161.49%
2018 -74.42%
2017 -25.77%
2016 -17.55%
2015 -23.54%
2014 5.79%
2013 64.85%
2012 -53.76%
2011 -27.98%
2010 4.29%
2009 128.98%
2008 -89.60%
2007 -24.17%
2006 39.08%
2005 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$527.87 33.33%
US
$873.57 35.10%
NL
$741.32 8.41%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE